Hiyama, H <br/><br/>
Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.  [electronic resource] 

 -  Oncogene  Mar 1998 
 - 1513-23 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0950-9232 
<br/><br/><label>Standard No.: </label>10.1038/sj.onc.1201667  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Binding Sites--genetics<br/>Carrier Proteins<br/>Cell Cycle--genetics<br/>Cell Cycle Proteins<br/>Cyclin-Dependent Kinase Inhibitor p21<br/>Cyclins--genetics<br/>DNA-Binding Proteins<br/>E2F Transcription Factors<br/>E2F1 Transcription Factor<br/>E2F4 Transcription Factor<br/>Enzyme Inhibitors--metabolism<br/>G1 Phase--genetics<br/>Gene Expression Regulation, Neoplastic<br/>Glioma<br/>Humans<br/>Mice<br/>Promoter Regions, Genetic--genetics<br/>Retinoblastoma-Binding Protein 1<br/>S Phase--genetics<br/>Transcription Factor DP1<br/>Transcription Factors--metabolism<br/>Tumor Cells, Cultured